{"address1": "1111 Lincoln Road", "address2": "Suite 500", "city": "Miami Beach", "state": "FL", "zip": "33139", "country": "United States", "phone": "702 514 4174", "website": "https://www.pasithea.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Pasithea Therapeutics Corp., a biotechnology company, engages in discovery, research, and development of treatments for central nervous system disorders, RASopathies, and other diseases. Its lead product candidate PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 oncology indications. The company intends to develop PAS-003, to treat amyotrophic lateral sclerosis; and PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Dr. Lawrence  Steinman BA, M.D., Ph.D.", "age": 76, "title": "Co-Founder, MD & Executive Chairman", "yearBorn": 1948, "fiscalYear": 2024, "totalPay": 250000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tiago Reis Marques M.D., Ph.D.", "age": 46, "title": "CEO & Director", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 450000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel H. Schneiderman", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 330000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.0182, "open": 0.0202, "dayLow": 0.0182, "dayHigh": 0.0182, "regularMarketPreviousClose": 0.0182, "regularMarketOpen": 0.0202, "regularMarketDayLow": 0.0182, "regularMarketDayHigh": 0.0182, "beta": 0.749, "volume": 200, "regularMarketVolume": 200, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fiftyTwoWeekLow": 0.0182, "fiftyTwoWeekHigh": 0.0182, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "profitMargins": 0.0, "floatShares": 2594077, "bookValue": 10.603, "priceToBook": 0.0017164955, "netIncomeToCommon": -13904584, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 0.0182, "recommendationKey": "none", "totalCash": 6922729, "totalCashPerShare": 2.559, "ebitda": -13600933, "totalDebt": 0, "quickRatio": 6.182, "currentRatio": 6.58, "returnOnAssets": -0.42228, "returnOnEquity": -0.72835, "freeCashflow": -9000477, "operatingCashflow": -13923438, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "KTTAW", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Pasithea Therapeutics Corp. Warrant", "longName": "Pasithea Therapeutics Corp.", "regularMarketChange": 0.0, "regularMarketDayRange": "0.0182 - 0.0182", "fullExchangeName": "NasdaqCM", "fiftyTwoWeekLowChange": 0.0, "fiftyTwoWeekLowChangePercent": 0.0, "fiftyTwoWeekRange": "0.0182 - 0.0182", "fiftyTwoWeekHighChange": 0.0, "fiftyTwoWeekHighChangePercent": 0.0, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-09-15", "cryptoTradeable": false, "hasPrePostMarketData": true, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.0182, "corporateActions": [], "regularMarketTime": 1742932800, "exchange": "NCM", "messageBoardId": "finmb_702706441", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "displayName": "Pasithea Therapeutics", "trailingPegRatio": null}